Third edition. Edited by Steven A. Rosenberg. 916 pp., illustrated. Philadelphia, Lippincott Williams & Wilkins, 2000. $179. ISBN 0-7817-2272-1.
In a 1987 editorial accompanying two reports on the use of interleukin-2for treating advanced cancer, John Durant, after several callsfor caution, concluded that perhaps we were at the end of thebeginning of the search for successful immunotherapy for cancer(N Engl J Med 1987;316:939-941). Fifteen years later, the thirdedition of Principles and Practice of the Biologic Therapy ofCancer illustrates the extraordinary development that has takenplace in the field but also, as underlined by the variety oftherapeutic approaches still being investigated, demonstratesthat biologic therapy is still in its infancy and that thereis . . . [Full Text of this Article]
Previous
